- Canada's Apotex must pay AstraZeneca (AZN -0.1%) $76M in damages tied to the generic drug maker's sale of generic Prilosec.
- The award amounts to 50% of the profits Apotex earned selling the drug over three-and-a-half years.
- The patent infringement portion of the case was already decided (in 2007) and thus only the judgement amount is new.
AstraZeneca wins $76M in Prilosec generic case
Dec 3 2013, 15:00 ET